Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chiglitazar Versus Metformin for Insulin Resistance in Non-obese Patients With Polycystic Ovary Syndrome

NCT06125587 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT06125587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06125587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chiglitazar Versus Metformin for Insulin Resistance in Non-obese Patients With Polycystic Ovary Syndrome
Lead sponsor
Shengjing Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
November 15, 2023
Completion date
November 20, 2024
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chiglitazar, metformin, polycystic ovary syndrome